Olema Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript
Thank you, everyone, for joining us at another session here at the 2022 Jefferies Global Healthcare Conference. Happy to have up here with me the President and CEO of Olema Oncology, Sean Bowen. Sean, it's great to see you.
Questions & Answers
I would love to just maybe start off with a topic that I think is important to address, which is this whole landscape of SERD in breast cancer. And this idea that certainly here in the Wall Street community, in the financial community, a lot of, I guess, confusion about how to think about SERDs. There are pharma companies here that were just downstairs. They've had various mixed results in SERD. And so Wall Street says [well] that's not great. And then you have a bunch of smaller biotechs that have also presented data. You even have one that's on file at the FDA currently. So a lot going on.
And maybe you could just start from the top and say, hey, why should we be interested in Olema's SERD? And why is Wall Street -- shouldn't be confused?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
